CHU Dijon Bourgogne
Dijon, France
Location status: Recruiting
NCT Number: NCT05945199
The aim of this research is to evaluate the efficacy of a new treatment for chemsex or "chemical sex", the use of psychoactive substances to modify sexual experience and performance. This treatment, called Transcranial direct current stimulation (tDCS) aims to modulate the cortical activity of brain areas involved in the desire to use psychoactive substances, or drugs, and the desire for uncontrolled sexual intercourse.
This treatment should therefore lead to a reduction in the craving for consumption of psychoactive substances and/or the practice of uncontrolled sexual activity.
The stakes of this new treatment are high, because chemsex exposes people to health risks for themselves and others. These risks include the risk of infection (skin infections, HIV infection, hepatitis viruses), psychological harms (anxiety attacks, depression, suicide risk), risk of addiction (addiction to the psychoactive product used, sex addiction), and toxicological harm (overdose, dangerous combination of psychoactive substances) or trauma (blows, trauma to the genitals or anorectal trauma).
To date, there is no proven therapeutic treatment for people wishing to reduce or stop chemsex.
40 participants will be randomized into 2 groups:
* 20 patients will receive active stimulation * 20 patients will receive sham stimulation
The total duration of the study for each patient will be 13 weeks: 1 week of stimulation and 12 weeks of follow-up.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Dijon, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of risk behaviours (retrospective exploration by the categorical rating of frequency: At least once a day - Several times a week several times a week - once a week - several times a month - once a month - less than once a month - never). times a month - Once a month - Less than once a month - Never)
EVA craving index for chemsex Maximum VAS craving in the week preceding assessment for chemsex, sexual practices and use of psychoactive substances, HAqII, CSBD-19, modified CCQ-brief, SDI, BDI-II
Time frame: 4 weeks from end of stimulation (S5)
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire Dijon
Other
Acronym: CHEMSTIM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07509853
Behavior, Chemically-Induced Disorders
Pathum Wan, Bangkok, Thailand
View Trial DetailsNCT07512856
Behavior, Chemically-Induced Disorders
Pathum Wan, Bangkok, Thailand
View Trial DetailsNCT06610916
Addiction, Behavior
Paris, France
View Trial DetailsNCT07512869
Behavior, Chemically-Induced Disorders
Pathum Wan, Bangkok, Thailand
View Trial Details